About this trial

To examine how we can provide supportive care for patients with advanced cancer better tailored to their needs

Eligibility criteria

Qualifiers

Age ≥ 18

Outpatients who are within 12 weeks of diagnosis of metastatic solid tumors and seen by one of the participating medical oncologists

Eastern Cooperative Oncology Group Performance Status 0.2

Able to speak English or Spanish

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Questionnaire and Physical Exam

Treatment groups

300 Participants
are divided into 3 treatment groups

Locations

1
MD Anderson Cancer Center77030, HoustonTexas, United States

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

National Institutes of Health (NIH)

Collaborator